Log in or Sign up for Free to view tailored content for your specialty!
Sjögren’s Syndrome News
Direct-to-consumer genetic testing not ready for prime time in rheumatology
Splashy headlines in the mainstream media that proclaim advances in medicine are often not what they seem. That may be the case with a recent series of FDA approvals surrounding the direct-to-consumer genetic testing platform, 23andMe.
Sjögren's syndrome linked to increased cardiovascular comorbidity
Primary Sjögren’s syndrome is associated with increased cardiovascular comorbidities, according to data published in Arthritis Care & Research.
Log in or Sign up for Free to view tailored content for your specialty!
Few rheumatic adverse events from immune checkpoint inhibitors require discontinuation
Researchers found that the most prevalent adverse effect linked to immune checkpoint inhibitors was inflammatory arthritis, and although most patients received long courses of immune suppression, few required checkpoint inhibitor discontinuation, according to data published in Arthritis & Rheumatology.
Recapping the ACR Review Course: What You May Have Missed This Year
I always look forward to the ACR yearly review course for an engaging way to get updates on various topics in the field of rheumatology. It’s also a way to reminisce what it’s like to be a high primary school student again and makes you wonder how you were ever able to sit in the same seat all day long, day after day!
Rheumatologists 'must' respond to checkpoint inhibitor problem
CHICAGO — Rheumatologists, as well as the rheumatology specialty as a whole, must become more aware of, and develop treatments and guidelines for, the problem of rheumatologic side effects related to checkpoint inhibitor therapy, according to Peter A. Merkel, MD, MPH, of the University of Pennsylvania.
Wearable devices linked to increased activity in rheumatic diseases
The use of wearable devices that track movement is effective in significantly increasing the amount of and time spent performing moderate to vigorous physical activity, with high short-term adherence, among patients with rheumatic and musculoskeletal diseases, according to findings published in Arthritis Care & Research.
ACR report card: Majority of states score 'C' for rheumatology care
The 2018 Rheumatic Disease Report Card: Raising the Grade on Rheumatology Care in America released today by the American College of Rheumatology demonstrates that access to affordable rheumatology care varied considerably from state to state, with most states averaging a “C” grade.
A Diagnosis Divided
We begin with a 24-year-old previously healthy female presenting with gradual worsening — over the last few months — migraine-like headaches accompanied by nausea but no vomiting. She was in a usual state of health when she started getting headaches, that were described as intermittent with a deep ache sensation. The headaches were unilateral and would switch from left to right and sometimes occur between the eyes. The patient described the severity as 8 out of 10. The headaches did not wake her from sleep, and she was unsure of what triggered them. She denied hearing loss, tinnitus, numbness or tingling of extremities, weakness, joint pain, joint swelling or rashes. She reported no new medications.
Less than one-third of reproductive-age women with rheumatic disease use prescription contraception
Just 32.1% of reproductive-age women with rheumatic diseases use any kind of prescription contraception, while at the same time more than 70% use at least one fetotoxic medication, according to findings published in Arthritis Care & Research.
Two-factor interferon score, family history predict connective tissue disease progression
Physicians and rheumatologists can use a two-factor interferon score and family history to predict a patient’s progression from being antinuclear-antibody positive to developing autoimmune connective tissue diseases, such as systemic lupus erythematosus or Sjögren’s syndrome, according to findings published in the Annals of the Rheumatic Diseases.
-
Headline News
FDA warns of potential liver injury with Veozah for menopausal hot flashes
September 12, 20242 min read -
Headline News
Video games improved mental health during COVID-19 pandemic
September 12, 20242 min read -
Headline NewsSeptember 12, 20240 min read
-
Headline News
FDA warns of potential liver injury with Veozah for menopausal hot flashes
September 12, 20242 min read -
Headline News
Video games improved mental health during COVID-19 pandemic
September 12, 20242 min read -
Headline NewsSeptember 12, 20240 min read